Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Capital Markets

Guangzhou Tinci Materials Technlgy / Equity Capital Markets

Guangzhou Tinci Materials Technlgy (002709 CH)

<ul>
<li>Tinci is seeking an A+H listing. JPM, CITIC, and GF are the joint sponsors.</li>
<li>We look at the company's two core segments: battery materials and daily and specialty chemicals.</li>
<li>We discuss our preliminary thoughts on the company's fair value based on A-H premium.</li>
</ul>


Tinci is seeking an A+H listing. JPM, CITIC, and GF are the joint sponsors.
We look at the company's two core segments: battery materials and daily and specialty chemicals.
We discuss our preliminary thoughts on the company's fair value based on A-H premium.


Tinci (天赐材料) A+H Pre-IPO: Early Thoughts